Approaching complete inhibition of P-glycoprotein at the human blood-brain barrier: an (R)-[11C]verapamil PET study.
about
Factors Governing P-Glycoprotein-Mediated Drug-Drug Interactions at the Blood-Brain Barrier Measured with Positron Emission Tomography.CNS uptake of bortezomib is enhanced by P-glycoprotein inhibition: implications for spinal muscular atrophyPilot PET Study to Assess the Functional Interplay Between ABCB1 and ABCG2 at the Human Blood-Brain BarrierThe possible use of the L-type calcium channel antagonist verapamil in drug-resistant epilepsy.Effect of P-glycoprotein inhibition at the blood-brain barrier on brain distribution of (R)-[11 C]verapamil in elderly vs. young subjects.Use of PET Imaging to Evaluate Transporter-Mediated Drug-Drug Interactions.Imaging transporters: Transforming diagnostic and therapeutic development.Leishmanicidal candidate LASSBio-1736, a cysteine protease inhibitor with favorable pharmacokinetics: low clearance and good distribution.Blood-brain barrier dysfunction and recovery after ischemic stroke.Towards Improvements for Penetrating the Blood-Brain Barrier-Recent Progress from a Material and Pharmaceutical Perspective.Pharmacokinetics of the P-gp Inhibitor Tariquidar in Rats After Intravenous, Oral, and Intraperitoneal AdministrationMechanisms and the clinical relevance of complex drug-drug interactionsDrug Transport at the Brain and Endothelial Dysfunction in Preeclampsia: Implications and Perspectives
P2860
Q36049576-A0B4D32C-37B0-4E1F-A744-6207D6E93363Q36618001-9199C49F-EC77-41D8-A649-28F1C1A80474Q37164563-EDC7C8D7-0B9D-423D-B8DE-D4D92E7CE2EEQ38633232-D32FDB0E-0AD5-45B2-94EB-C5669DC0C6EDQ38841102-6D0DE719-DC30-45C2-A06E-008EBAEE55C7Q38844653-3F5A8305-42E7-4F80-A101-47DBDA08EDBEQ38871905-3F4FB9EC-42F9-4EBC-AF35-D00B9AA8F600Q47379695-2F595790-C890-4142-B22B-BE10DCC88814Q47910464-40C1965A-6263-44B7-BF29-6225F8C1D47BQ55058268-C3AD9FCA-F3A1-4257-BC38-7A44EDA99A57Q57137963-E25417C3-C279-43F2-BB3F-A6459746E544Q57490721-4B32D553-A122-4D83-B3CD-E923E71A7B3BQ59136492-6E7CF154-F71F-45D2-AF44-25B8A92CE676
P2860
Approaching complete inhibition of P-glycoprotein at the human blood-brain barrier: an (R)-[11C]verapamil PET study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Approaching complete inhibitio ...... (R)-[11C]verapamil PET study.
@en
type
label
Approaching complete inhibitio ...... (R)-[11C]verapamil PET study.
@en
prefLabel
Approaching complete inhibitio ...... (R)-[11C]verapamil PET study.
@en
P2093
P2860
P50
P356
P1476
Approaching complete inhibitio ...... n (R)-[11C]verapamil PET study
@en
P2093
Alexandra Maier-Salamon
Johann Stanek
Kerstin Römermann
Marcus Hacker
Markus Müller
Rudolf Karch
Walter Jäger
P2860
P304
P356
10.1038/JCBFM.2015.19
P577
2015-02-11T00:00:00Z